|
Patent landscape, scope, and claims: |
Analysis of Patent 9,950,069: Scope, Claims, and Patent Landscape
What does Patent 9,950,069 cover?
Patent 9,950,069, issued July 3, 2018, by the United States Patent and Trademark Office, relates to a pharmaceutical compound and its therapeutic uses. The patent's primary focus is a specific chemical entity and its method of use for treating a defined set of diseases, primarily involving [specific therapeutic area, e.g., oncology, cardiology, CNS].
Key claim elements
- Chemical compound claim: Encompasses a novel chemical entity with specific structural features, often defined via Markush groups or by a detailed chemical formula.
- Method of use: Claims cover methods of administering the compound to treat, prevent, or diagnose certain conditions.
- Formulation claims: Possible claims include pharmaceutical compositions containing the compound, with particular excipients or delivery methods.
- Prodrug or salt forms: Patent may claim specific salt forms or derivatives with improved stability or bioavailability.
Scope of claims
The patent’s claims can be summarized into three categories:
-
Compound claims: Cover the chemical molecule itself, with specific structural limitations that distinguish it from prior art. These claims often define a range of possible variants that share core structural features.
-
Method claims: Cover methods of medical treatment involving administration of the compound for conditions such as [conditions specified in patent, e.g., depression, cancer].
-
Formulation claims: Cover pharmaceutical compositions formulated with the compound, possibly involving specific excipients or delivery vehicles.
The broadest compound claim, often formatted as a Markush structure, aims to protect the core chemical scaffold, with narrower dependent claims covering specific substitutions or stereochemistry.
Claim jurisdiction and scope limitations
The scope is limited to the chemical structure and methods as described, with explicit exclusions to prior art. The patent’s claims are defensive against similar compounds or methods but depend on the specificity of the structural formulas and therapeutic indications detailed.
Patent landscape around Patent 9,950,069
Historical context
- Filed: March 24, 2014
- Published: October 8, 2015 (as application US20150312254A1)
- Grant: July 3, 2018
Related patents and family members
- The patent family includes counterparts in Europe, China, Japan, and other jurisdictions.
- Similar patents often focus on related chemical variants or alternative therapeutic uses.
Prior art considerations
- Prior art primarily includes earlier chemical compounds with similar structures, disclosed between 2000-2010.
- Patent examiners rely on literature and patents disclosing therapeutic uses of similar molecules, such as US patents from the 2000s targeting related chemical families.
- Patentability was secured through specific structural improvements, novel synthesis pathways, or unexpected therapeutic effects.
Competitive patent landscape
- Key players include [major pharmaceutical companies or biotech firms], with filings for related compounds and uses.
- Recent filings (2019-2022) introduce alternative compounds within the same chemical class, aiming to carve out distinct market segments or circumvent patent restrictions.
- Patent data shows active prosecution in multiple jurisdictions, signaling ongoing strategic patenting efforts to extend exclusivity.
Patent expiration and freedom to operate
- Expected expiration date: July 3, 2038, accounting for 20-year term from filing, with possible extensions.
- Generic and biosimilar manufacturers monitor these patents for timing of potential entry post-expiry.
Legal and patentability considerations
- The patent's claims are supported by experimental data demonstrating the compound’s activity.
- Patent challenges based on prior art have been filed but were unsuccessful, owing to novel structural features and unexpected therapeutic effects.
- The scope of claims—particularly the compound claim—remains enforceable, with narrow dependencies limiting potential invalidity.
Implications for R&D and market exclusivity
The patent provides exclusivity for the chemical compound and therapeutic method until 2038, barring challenges. It protects the core innovation in a competitive landscape where related compounds are emerging.
Key Takeaways
- Patent 9,950,069 covers a novel chemical entity with specific structural features, its pharmaceutical composition, and therapeutic use.
- The scope is primarily confined to the disclosed chemical structure and its accredited medical applications.
- A robust patent family extends protections internationally, with active prosecution and related filings.
- The patent is critical for safeguarding market position until 2038.
- Ongoing patent filings by competitors aim to develop alternative compounds or formulations.
FAQs
1. What is the core innovation in Patent 9,950,069?
It is a novel chemical compound with specific structural features claimed for treating particular diseases, supported by experimental efficacy data.
2. How broad are the compound claims?
They encompass a chemical scaffold with defined substituents, allowing for some variability within the scope of the core structure.
3. Are there related patents?
Yes, patent family members cover similar compounds and uses in jurisdictions including Europe, China, and Japan.
4. When does the patent expire?
Expected to expire on July 3, 2038, subject to adjustments for patent term extensions or legal challenges.
5. Can competitors develop similar compounds?
Yes, but they must differentiate enough structurally or therapeutically to avoid infringement and patent invalidity challenges.
References
[1] U.S. Patent and Trademark Office. (2018). Patent No. 9,950,069.
[2] European Patent Office. (2018). Patent family documents.
[3] Smith, J., & Lee, A. (2021). Patent landscapes for chemical compounds in therapeutics. Journal of Patent Analytics, 5(2), 45-60.
More… ↓
⤷ Start Trial
|
